Blog
The global pandemic and continued supply chain disruptions have prompted many U.S. pharmaceutical and medical device manufacturers to reassess their reliance on offshore production. As organizations place greater emphasis on quality assurance, regulatory compliance, and supply chain resilience, onshoring manufacturing has become a strategic priority. Bringing operations back to the United States allows companies to strengthen oversight, enhance manufacturing reliability, and establish greater control over GMP processes.
One of the most important early decisions in this process is choosing between a brownfield facility or a greenfield manufacturing site. This choice influences implementation timelines, operational efficiency, regulatory readiness, and long-term scalability.
What Is a Brownfield Facility?
A brownfield manufacturing facility is an existing structure that can be repurposed to support new or expanded operations. Companies may lease or purchase the facility and complete the modifications required to support production. In many cases, the site already includes established utilities, cleanroom environments, operational workflows, and experienced personnel.
Some organizations may even have suitable brownfield options within their own corporate network. During evaluation, many rely on GMP facility design review to ensure the site meets modern standards.
Advantages of Brownfield Sites
Brownfield facilities are often preferred for their speed and efficiency. Since construction is not required, manufacturers can begin operations much sooner. This shortens transition timelines, reduces downtime, and supports faster technology transfer. Existing quality systems such as QMS, ERP platforms, CAPA management systems, and electronic documentation tools can also be integrated into the new operational framework. Organizations often turn to quality management system optimization to ensure alignment.
Challenges of Brownfield Sites
Older buildings may have structural or layout limitations that restrict scalability. Aging equipment may introduce inefficiencies or require significant upgrades to meet current expectations under FDA and EU guidance. Before transitioning, manufacturers should assess the site’s validation status and consider FDA inspection readiness services to identify potential compliance gaps.
What Is a Greenfield Facility?
A greenfield manufacturing site involves constructing a new facility from the ground up. This approach gives pharmaceutical and medical device companies complete freedom to design a building aligned with modern GMP compliance standards and advanced technologies.
Greenfield sites also allow companies to incorporate optimized cleanroom layouts and contamination control strategies that support sterile manufacturing and are consistent with EU Annex 1–style risk management.
Advantages of Greenfield Sites
A new build allows manufacturers to design workflows that reduce contamination risk, integrate advanced utilities, and install state-of-the-art equipment. A greenfield project also enables scalable infrastructure planning for future growth and long-term efficiency. Many companies leverage regulatory compliance support early in the design phase to ensure alignment with FDA and global expectations.
Challenges of Greenfield Sites
Greenfield facilities have longer timelines, higher upfront costs, and expanded staffing requirements. Construction delays, permitting schedules, and supply chain challenges can further extend project timelines. Organizations frequently use process validation support and technology transfer services to ensure smooth startup once the facility becomes operational.
Choosing the Right Onshoring Strategy
Selecting between a brownfield and a greenfield strategy requires a comprehensive assessment of:
- The complexity of your manufacturing process
- Speed-to-market requirements and timelines
- Long-term capacity and scalability needs
- Regulatory risk and inspection risk (FDA, global)
- Maturity of your quality system and digital infrastructure
- Total cost of ownership (capex, opex, validation)
Get Expert Support From Regulatory Compliance Associates®
Whether you are planning a brownfield retrofit or building a greenfield facility, establishing a strong compliance foundation from the very beginning is essential. Regulatory Compliance Associates® (RCA) delivers full-lifecycle support for life science companies, including:
- GMP facility design reviews
- Quality system implementation and remediation (QMS)
- Inspection readiness and training, including mock FDA inspections, pre-inspection coaching, and audit preparation
- Regulatory consulting for FDA submissions, global strategy, and agency communications
- Process validation, technology transfer, and risk management to ensure robust, compliant operations
- Supplier quality assurance to support stable raw materials and component sourcing
Partnering with RCA helps you align your onshoring strategy with regulatory needs, reduce compliance risk, and accelerate operational readiness. Our deep bench of industry and former-FDA experts will translate complex requirements into practical, actionable plans tailored to your organization.
Contact Regulatory Compliance Associates® today to connect with a subject matter expert and begin building a compliant, efficient, and future-ready manufacturing operation.
